Detection of a Substantial Rate of Multidrug‐Resistant Tuberculosis in an HIV‐Infected Population in South Africa by Active Monitoring of Sputum Samples
Authors:
- 1 April 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 50 (7) , 1053-1059
Abstract
Tuberculosis (TB) coinfection with human immunodeficiency virus (HIV) is a substantial problem in South Africa. There has been a presumption that drug-resistant strains of TB are common in South Africa, but few studies have documented this impression. In Phidisa, a joint observational and randomized HIV treatment study for South African National Defence Force members and dependents, an initiative was launched to test subjects (by use of microbiologic TB test) who appeared to be at high risk. We report results for HIV-infected subjects. TB was identified by culture in 116 (19.9%) of 584 patients selected for sputum examination on the basis of suggestive symptoms. Smear was an insensitive technique for confirming the diagnosis: only 33% of culture-positive patients were identified by smear, with a 0.2% false-positive rate. Of the 107 culture-positive individuals with susceptibility testing, 22 (20.6%) were identified to be multidrug resistant (MDR), and 4 (3.7%) were identified to be extensively drug resistant. Culture-positive cases with a history of TB treatment had more than twice the rate of MDR than those without (27.1% vs 11.9%; P = .05). TB is common in this cohort of HIV-infected patients. Smear was not a sensitive technique for identifying culture-positive cases in this health system. Drug susceptibility testing is essential to proper patient management because MDR was present in 20.6% of culture-positive patients. Better management strategies are needed to reduce the development of MDR TB, because so many of these patients had received prior antituberculous therapy that was presumably not curative.Keywords
This publication has 25 references indexed in Scilit:
- The Global Burden of Tuberculosis — Combating Drug Resistance in Difficult TimesNew England Journal of Medicine, 2009
- High Sensitivity and Specificity of Acid-Fast Microscopy for Diagnosis of Pulmonary Tuberculosis in an African Population with a High Prevalence of Human Immunodeficiency VirusJournal of Clinical Microbiology, 2009
- Novel Relationship between Tuberculosis Immune Reconstitution Inflammatory Syndrome and Antitubercular Drug ResistanceClinical Infectious Diseases, 2009
- Clinical Deterioration during Antitubercular Treatment at a District Hospital in South Africa: The Importance of Drug Resistance and AIDS Defining IllnessesPLOS ONE, 2009
- Faculty Opinions recommendation of Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis.2009
- Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trialAnnals of Clinical Microbiology and Antimicrobials, 2009
- Commercial Nucleic-Acid Amplification Tests for Diagnosis of Pulmonary Tuberculosis in Respiratory Specimens: Meta-Analysis and Meta-RegressionPLOS ONE, 2008
- Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis: Implications for the HIV Epidemic and Antiretroviral Therapy Rollout in South AfricaThe Journal of Infectious Diseases, 2007
- Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIVTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Update: Nucleic acid amplification tests for tuberculosis.2000